Prevention and Reversal of Antibody Responses Against Factor IX in Gene Therapy for Hemophilia B

Intramuscular (IM) administration of an adeno-associated viral (AAV) vector represents a simple and safe method of gene transfer for treatment of the X-linked bleeding disorder hemophilia B (factor IX, F.IX, deficiency). However, the approach is hampered by an increased risk of immune responses agai...

Descripción completa

Detalles Bibliográficos
Autores principales: Nayak, Sushrusha, Sarkar, Debalina, Perrin, George Q., Moghimi, Babak, Hoffman, Brad E., Zhou, Shangzhen, Byrne, Barry J., Herzog, Roland W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Research Foundation 2011
Materias:
Microbiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3260742/
https://www.ncbi.nlm.nih.gov/pubmed/22279442
http://dx.doi.org/10.3389/fmicb.2011.00244

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3260742/
https://www.ncbi.nlm.nih.gov/pubmed/22279442
http://dx.doi.org/10.3389/fmicb.2011.00244

Ejemplares similares